MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial

Houston, TX, May 15, 2009 --( MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project Management, Clinical and Regulatory services for the Phase III randomized, double-blind, placebo-controlled, cross-over trial.

“This award represents our client’s satisfaction with our previous work and is seen as a vote of confidence in our continued abilities and expertise. It further solidifies our commitment to expand and deepen our Central Nervous System and epilepsy trial experience as well as our relationship with the Epilepsy Consortium,” stated Eric Lund, President of MedSource.

“It is our intent to work toward establishing MedSource as a leader in this space,” added Lund.

MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. For more information, visit

About MedSource
MedSource is a premier Contract Research Organization (CRO) dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. They have quickly grown into one of the premier CROs in North America and have been recognized as an Inc. 500 company. With clinical trial monitors located throughout North America and active vendor relationships globally, MedSource is able to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at or by calling (281) 286-2003.

Melissa C. Gillespie